+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 1Year - 18Years
All Genders
ID06212609

Personalized Non-Invasive Brain Stimulation for Children and Teens with Drug-Resistant Partial Epilepsy

Led by Centre Hospitalier Universitaire, Amiens · Updated on 2024-01-31

20

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Epilepsy is a common neurological disorder affecting 0.5% to 1% of the population, often diagnosed in children and impacting quality of life. Around one-third of patients with focal epilepsy do not respond well to drug therapy, and while surgery can help, only a small percentage qualify due to localization challenges or risks of neurological damage. This study focuses on exploring new diagnostic and treatment approaches for drug-resistant partial epilepsy in children and adolescents. The trial evaluates a new non-invasive, personalized transcranial electrical stimulation therapy designed to manage pharmaco-resistant focal epilepsies. Participants aged 1 to 18 will receive optimized brain stimulation based on individual epileptic source mapping, aiming to reduce seizure frequency. This treatment is delivered without surgery and seeks to improve the precision and effectiveness of brain stimulation in this population. Participants will be monitored over 10 weeks to measure changes in their seizure numbers compared to baseline. The study includes EEG and magnetoencephalography examinations, structural MRI scans, and tracking of seizure frequency. Researchers will assess how well the transcranial electrical stimulation controls seizures and monitor safety and tolerability during the study period.

CONDITIONS

Brief Title

Optimized and Personalized Trans-cranial Brain Stimulation in Partial Refractory Epilepsies

Research Team

F

Fabrice Wallois, Pr

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here